Veterinary Medicine Information website

Lincospectin Lösung 50 mg/ml + 100 mg/ml, Injektionslösung für Schweine, Kälber, Hunde und Katzen

Authorised
  • Lincomycin hydrochloride monohydrate
  • Spectinomycin sulfate tetrahydrate
Download as PDF

Product identification

Medicine name:
Lincospectin Lösung 50 mg/ml + 100 mg/ml, Injektionslösung für Schweine, Kälber, Hunde und Katzen
Active substance:
  • Lincomycin hydrochloride monohydrate
  • Spectinomycin sulfate tetrahydrate
Target species:
  • Cattle (calf)
  • Dog
  • Cat
  • Pig
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Lincomycin hydrochloride monohydrate
    56.70
    milligram(s)
    /
    1.00
    millilitre(s)
  • Spectinomycin sulfate tetrahydrate
    151.20
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle (calf)
      • Meat and offal
        21
        day
    • Pig
      • Meat and offal
        12
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01RA94
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Germany
Available in:
  • Germany
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
  • Zoetis Deutschland GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Bela-Pharm GmbH & Co. KG
  • Zoetis Belgium SA
Responsible authority:
  • Federal Office Of Consumer Protection And Food Safety
Authorisation number:
  • 2107.00.00
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 28/07/2025
Download